The second quarter of 2024 marks a significant milestone for MediBloc. We extend our heartfelt gratitude to all of you for your continued support and interest. MediBloc’s growth has been possible because of your unwavering support.
During this quarter, MediBloc has achieved numerous milestones, and we are excited to share these accomplishments with you through our Q2 2024 report. This report will provide insights into the key activities and achievements from the past three months and outline our future plans.
3rd Party Service Partnership Update: Roche Korea Collaborates with Medipass
Medipass, operated by Weavrcare and leveraging the Panacea blockchain, has become a partner with Roche Korea to introduce a digital medication information service. This service enables patients to access information about Roche medications prescribed to them directly through the Medipass application. Integrated with hospitals, Medipass provides patients with guidance on medication usage, side effects, and precautions, enhancing convenience and reducing the risk of loss associated with paper-based information.
3rd Party Service Update: Dr.palette’s Active Participation in Various Conferences
In the second quarter of 2024, Dr.palette actively promoted its cloud-based EMR program by participating in several prestigious conferences. On April 23, 2024, Dr.palette attended the Korean Aesthetic Surgery & Laser Society conference, where they introduced their EMR program to the attending physicians. Following this, on May 7, 2024, they took part in the Korean Academy of Aesthetic Dermatology and Cosmetic Surgery Spring Conference. Lastly, on May 21, 2024, Dr.palette participated in the Korean Association for Laser, Dermatology and Trichology Spring Conference.
At each event, Dr.palette showcased their cloud-based EMR program to the doctors, receiving very positive feedback. The attendees were impressed with the program’s capabilities and its potential to enhance their practice. These conferences provided excellent opportunities for Dr.palette to connect with industry professionals, engage in meaningful discussions, and strengthen their presence in the medical community.
As we close the second quarter of 2024, we reflect on MediBloc’s significant progress. Our partner, Weavrcare, has made notable strides, such as collaborating with Roche Korea and introducing Dr.palette at various conferences. These achievements highlight the growing potential of our Panacea blockchain technology. Additionally, we are developing a service that allows the use of MED for accessing offline medical institutions and other services. We will update you with any new developments. We deeply appreciate the continuous support from our community. Looking ahead, we are excited to explore Panacea’s potential, strengthen our partnerships, and achieve new milestones together. Thank you for being part of our journey.